MALTOSE ANHYDROUS
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 342.0 | -5.4 | 8 | 11 | 190.0 | 4 | 1.0 |
- CAS
- 69794
- UNII
- 66Y63L379N
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 36 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT01562626 | 2012-09-01 | Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors | Phase 1/Phase 2 | Recruiting |
| NCT01146535 | 2011-01-01 | Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment | Phase 2 | Completed |